Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Sci Rep ; 11(1): 10323, 2021 05 14.
Article in English | MEDLINE | ID: mdl-33990639

ABSTRACT

MicroRNAs as cancer biomarkers in serum, plasma, and other body fluids are often used but analysis of miRNA in urine is limited. We investigated the expression of selected miRNAs in the paired urine, serum, cervical scrape, and tumor tissue specimens from the women with cervical precancer and cancer with a view to identify if urine miRNAs could be used as reliable non-invasive biomarkers for an early diagnosis and prognosis of cervical cancer. Expression of three oncomiRs (miR-21, miR-199a, and miR-155-5p) and three tumor suppressors (miR-34a, miR-145, and miR-218) as selected by database search in cervical pre-cancer, cancer, and normal controls including cervical cancer cell lines were analyzed using qRT-PCR. The expression of miRNAs was correlated with various clinicopathological parameters, including HPV infection and survival outcome. We observed a significant overexpression of the oncomiRs and the downregulation of tumor suppressor miRNAs. A combination of miR-145-5p, miR-218-5p, and miR-34a-5p in urine yielded 100% sensitivity and 92.8% specificity in distinguishing precancer and cancer patients from healthy controls and it well correlates with those of serum and tumor tissues. The expression of miR-34a-5p and miR-218-5p were found to be independent prognostic factors for the overall survival of cervical cancer patients. We conclude that the evaluation of the above specific miRNA expression in non-invasive urine samples may serve as a reliable biomarker for early detection and prognosis of cervical cancer.


Subject(s)
Biomarkers, Tumor/urine , Circulating MicroRNA/urine , Early Detection of Cancer/methods , Papillomavirus Infections/diagnosis , Uterine Cervical Neoplasms/diagnosis , Adult , Alphapapillomavirus/genetics , Alphapapillomavirus/isolation & purification , Biomarkers, Tumor/metabolism , Case-Control Studies , Cell Line, Tumor , Cervix Uteri/pathology , Cervix Uteri/virology , Circulating MicroRNA/metabolism , DNA, Viral/urine , Female , Gene Expression Profiling , Healthy Volunteers , Humans , Kaplan-Meier Estimate , Liquid Biopsy/methods , Male , MicroRNAs/metabolism , MicroRNAs/urine , Papillomavirus Infections/epidemiology , Papillomavirus Infections/urine , Papillomavirus Infections/virology , Prevalence , Prognosis , Prospective Studies , Uterine Cervical Neoplasms/mortality , Uterine Cervical Neoplasms/urine , Uterine Cervical Neoplasms/virology
2.
Nat Commun ; 11(1): 4225, 2020 08 24.
Article in English | MEDLINE | ID: mdl-32839463

ABSTRACT

Gallbladder cancer (GBC) is an aggressive gastrointestinal malignancy with no approved targeted therapy. Here, we analyze exomes (n = 160), transcriptomes (n = 115), and low pass whole genomes (n = 146) from 167 gallbladder cancers (GBCs) from patients in Korea, India and Chile. In addition, we also sequence samples from 39 GBC high-risk patients and detect evidence of early cancer-related genomic lesions. Among the several significantly mutated genes not previously linked to GBC are ETS domain genes ELF3 and EHF, CTNNB1, APC, NSD1, KAT8, STK11 and NFE2L2. A majority of ELF3 alterations are frame-shift mutations that result in several cancer-specific neoantigens that activate T-cells indicating that they are cancer vaccine candidates. In addition, we identify recurrent alterations in KEAP1/NFE2L2 and WNT pathway in GBC. Taken together, these define multiple targetable therapeutic interventions opportunities for GBC treatment and management.


Subject(s)
DNA-Binding Proteins/genetics , Frameshift Mutation , Gallbladder Neoplasms/genetics , Genetic Predisposition to Disease/genetics , Proto-Oncogene Proteins c-ets/genetics , Transcription Factors/genetics , Cancer Vaccines/genetics , Cancer Vaccines/immunology , Chile , DNA-Binding Proteins/immunology , DNA-Binding Proteins/metabolism , Gallbladder Neoplasms/diagnosis , Gallbladder Neoplasms/metabolism , Gene Expression Profiling/methods , Gene Expression Regulation, Neoplastic , Genomics/methods , Humans , India , Kelch-Like ECH-Associated Protein 1/genetics , Kelch-Like ECH-Associated Protein 1/metabolism , NF-E2-Related Factor 2/genetics , NF-E2-Related Factor 2/metabolism , Proto-Oncogene Proteins c-ets/immunology , Proto-Oncogene Proteins c-ets/metabolism , Republic of Korea , Transcription Factors/immunology , Transcription Factors/metabolism , Wnt Signaling Pathway/genetics , beta Catenin/genetics , beta Catenin/metabolism
3.
Colloids Surf B Biointerfaces ; 180: 75-82, 2019 Aug 01.
Article in English | MEDLINE | ID: mdl-31030023

ABSTRACT

The present study reports the fabrication of Xylan/Chitosan/Montmorillonite (MMT) composite scaffold by freeze drying process with the aim of achieving improved properties for bone tissue engineering applications. The scaffolds were characterized using Fourier transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), Scanning electron microscopy (SEM) and mechanical testing. The fabricated scaffolds were found to be highly porous with variations in pore size (102 µm-290 µm) on varying the filler concentration. XRD study revealed complete exfoliation of MMT incorporated in polymer conjugates (Xylan/Chitosan) prepared by Maillard reaction. In-vitro bio-mineralization study revealed significant apatite deposition on polymer matrix. Scaffolds with 5% MMT concentration exhibited needle like morphology of deposited apatite which can further provide synergistic response in increasing the mechanical properties of scaffolds when placed in contact with body fluid. The average length and thickness of apatite needles were calculated to be 140 µm and 1.2 µm respectively. The deposited apatite crystals on scaffold with 2% MMT content demonstrated Ca/P ratio of 1.67, resembling that of natural bone apatite. Swelling and biodegradation behavior of scaffold were also studied with regard to hydrophilic and barrier effect of MMT on composites. MTT assay revealed non-cytotoxic nature of scaffold with good cell viability.


Subject(s)
Bentonite/chemistry , Biocompatible Materials/chemistry , Chitosan/chemistry , Glycoconjugates/chemistry , Tissue Engineering/methods , Xylans/chemistry , Bentonite/pharmacology , Biocompatible Materials/pharmacology , Cell Adhesion/drug effects , Cell Line, Tumor , Cell Survival/drug effects , Chitosan/pharmacology , Glycoconjugates/pharmacology , Humans , Osteoblasts/cytology , Osteoblasts/drug effects , Osteoblasts/physiology , Porosity , Tissue Scaffolds , Xylans/pharmacology
4.
J Cancer Res Ther ; 13(2): 235-239, 2017.
Article in English | MEDLINE | ID: mdl-28643740

ABSTRACT

BACKGROUND: Telomeres, which are bound with shelterin protein complex, play an important role in maintaining genomic stability and its dysfunction may lead to carcinogenesis. Here, we aimed to analyze whether shelterin complex gene expression and telomere length variation, play any role in gallbladder carcinogenesis. METHODS: Telomere length analysis was carried out by monochrome multiplex qPCR, whereas expression analysis of shelterin genes was carried out using RT-qPCR. Statistical analysis was carried out using SigmaPlot 11 software. RESULTS: We found significantly reduced telomere length in tumor tissues, and this reduction was seen in both, tumors with or without gallstones in comparison to adjacent non tumor and gallstone (chronic calculous cholecystitis: Inflamed) tissues. Inflamed tissues showed increased telomere length as compared to both adjacent non tumor and tumor tissues. Expression analysis of five shelterin genes showed significant downregulation of TERF1, POT1, and TINF2 genes in inflamed tissues as compared to non tumor and tumor tissues. POT1 was also found to be significantly upregulated in tumor tissues and specifically in tumor tissues with gallstones compared to inflamed tissues. CONCLUSION: This study, thus, suggests that, gallstone does not affect telomere length and even after having increased telomere length, decreased expression of some shelterin genes in inflamed tissue might cause telomeres to cap improperly, possibly leading to telomere dysfunction and further, gallbladder carcinogenesis. Also, increased expression of POT1 in tumor tissues with gallstones could act as a diagnostic marker in patients with gallstones.


Subject(s)
Gallbladder Neoplasms/genetics , Gene Expression Profiling , Telomere-Binding Proteins/genetics , Telomere , Humans , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Shelterin Complex
5.
Indian J Med Res ; 146(6): 768-773, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29664036

ABSTRACT

BACKGROUND & OBJECTIVES: Sahariya, a primitive tribe of Central India, has shown significantly increased incidence of pulmonary tuberculosis (PTB). Our previous study on Sahariya showed a significant association of -403G>A single nucleotide polymorphism (SNP) of CCL5 with susceptibility to PTB. Hence, this study was aimed to analyze a genotype-phenotype relationship of this disease-associated SNP to develop a potential diagnostic marker for TB in this tribe. METHODS: The present study was carried out on 70 plasma samples from Sahariya tribe, wherein the plasma CCL5 level was determined using a commercially available ELISA kit. RESULTS: The level of CCL5 decreased significantly in patients who were on therapy/completed their therapy [inactive TB patient/inactive PTB (IPTB)], particularly with AA genotype of -403G>A (P=0.046). The level, with AA genotype, was also found to gradually decrease in sputum 3+ and 1+/2+ than in sputum-negative samples. Similarly, the CCL5 level was found to be higher in sputum-positive/active TB patients than in IPTB group and healthy controls. INTERPRETATION & CONCLUSIONS: Our results suggested that the CCL5 level was influenced collectively not only by the genotypes of -403G>A SNP and bacillary load but also by the treatment. Thus, CCL5 may be considered for the development of a diagnostic marker and also as an indicator of recovery.


Subject(s)
Chemokine CCL5/genetics , Genetic Predisposition to Disease , Tuberculosis, Pulmonary/genetics , Tuberculosis, Pulmonary/microbiology , Adult , Female , Genetic Association Studies , Genotype , Haplotypes , Humans , Male , Middle Aged , Phenotype , Polymorphism, Single Nucleotide/genetics , Sputum/drug effects , Sputum/microbiology , Tuberculosis, Pulmonary/blood , Tuberculosis, Pulmonary/drug therapy
6.
Indian J Med Res ; 143(Supplement): S82-S90, 2016 May.
Article in English | MEDLINE | ID: mdl-27748282

ABSTRACT

BACKGROUND & OBJECTIVES: Loss of function of adenomatous polyposis coli (APC) has been reported in cancer. The two promoters of APC, 1A and 1B also have roles in cancer. But, the epigenetic role of APC promoters is not yet clear in gallbladder cancer (GBC) and gallstone diseases (GSD). We undertook this study to determine the epigenetic role of APC in GBC and GSD. METHODS: Methylation-specific (MS)-PCR was used to analyze the methylation of APC gene. The expression of APC gene was studied by semi-quantitative PCR, real-time PCR and immunohistochemistry (IHC) in GBC, GSD and adjacent normal tissues. RESULTS: Of the two promoters, APC 1A promoter was found methylated in 96 per cent GBC ( P=0.0155) and 80 per cent GSD (P=0.015). Exon 1 was downregulated in grade II (P=0.002) and grade III (P=0.0001) of GBC, while exon 2 was normally expressed. Scoring analysis of IHC revealed 0 or negativity in 34.48 per cent (P=0.057) and 1+ in 24.14 per cent (P=0.005) GBC cases suggesting loss of APC expression. INTERPRETATION & CONCLUSIONS: The present findings indicate epigenetic silencing of APC in advanced GBC. The methylation pattern, followed by expression analysis of APC may be suggested for diagnostic, prognostic and therapeutic purposes in GBC in future.


Subject(s)
Adenomatous Polyposis Coli Protein/genetics , DNA Methylation/genetics , Epigenesis, Genetic , Gallbladder Neoplasms/genetics , Adult , Exons , Female , Gallbladder Neoplasms/pathology , Gene Expression Regulation, Neoplastic , Humans , Male , Middle Aged , Prognosis , Tissue Array Analysis
7.
Tumour Biol ; 37(11): 14687-14699, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27623942

ABSTRACT

Promoter methylation in various tumor suppressor genes is reported to influence gallbladder carcinogenesis. Here, we aimed to identify methylation status in gallbladder cancer (GBC) by performing a comprehensive genome-wide DNA methylation profiling. The methylation status of 485,577 CpG sites were investigated using Illumina's Infinium Human Methylation 450 BeadChip array in 24 tissues (eight each of tumor, adjacent non-tumor, and gallstone). About 33,443 differentially methylated sites (DMRs) were obtained in the whole human genome, of which 24,188 (72 %) were hypermethylated and 9255 (28 %) were hypomethylated. The data also revealed that majority of the DMRs are localized on the proximal promoter region [Transcription start sites (TSS200, TSS1500) and 5' untranslated region (5'UTR)] and first exon. Exclusion of first exon detected a total of 10,123 (79 %) hypermethylated and 2703 (21 %) hypomethylated sites. Comparative analysis of the later with our differential proteomics data resulted in identification of 7 hypermethylated or down-regulated (e.g., FBN1, LPP, and SOD3) and 61 hypomethylated or up-regulated markers (e.g., HBE1, SNRPF, TPD52) for GBC. These genes could be further validated on the basis of their methylation/expression status in order to identify their utility to be used as biomarker/s for early diagnosis and management of GBC.


Subject(s)
Biomarkers, Tumor/genetics , DNA Methylation , Gallbladder Neoplasms/genetics , Gallstones/genetics , Gene Expression Profiling , Genome, Human , Promoter Regions, Genetic/genetics , CpG Islands/genetics , Epigenomics , Female , Follow-Up Studies , Gallbladder Neoplasms/pathology , Gallstones/pathology , Humans , Male , Middle Aged , Neoplasm Grading , Prognosis , Transcription Initiation Site
8.
J Hepatobiliary Pancreat Sci ; 23(5): 276-82, 2016 May.
Article in English | MEDLINE | ID: mdl-26856965

ABSTRACT

BACKGROUND: Telomeres play an important role in cancer progression. Recently it has been shown that subtelomeric methylation negatively regulates telomere length in various diseases, including cancers. Here, we evaluated the influence of subtelomeric methylation in telomere dysfunction in gallbladder cancer (GBC), and whether this dysfunction is affected by the presence of gallstones. METHODS: Relative telomere length and subtelomeric methylation levels were assessed using monochrome multiplex quantitative polymerase chain reaction and bisulfite sequencing, respectively, in different gallbladder tissue types including different grades of GBC, gallstones and adjacent non-tumor. RESULTS: We found telomere length to shorten significantly in overall GBC, but specifically in early grade cancer. We also found D4Z4 and DNF92 subtelomeric sequences to be hypermethylated and hypomethylated, respectively, in GBC; however, their methylation levels differed significantly, only in early grade cancer. We could not find any specific correlation between subtelomeric methylation and telomere length in GBC. Interestingly, telomere length and subtelomeric methylation differed significantly in GBC without gallstones but not in GBC with gallstones. CONCLUSIONS: This study, thus, suggests that telomere dysfunction and changes in methylation levels may occur earlier in the progression of GBC, while the presence of gallstones may have no influence on telomere length as well as on methylation levels.


Subject(s)
DNA, Neoplasm/genetics , Gallbladder Neoplasms/genetics , Gallstones/genetics , Genetic Predisposition to Disease , Adolescent , Adult , Aged , Aged, 80 and over , Child , DNA Methylation , Female , Gallbladder Neoplasms/epidemiology , Gallbladder Neoplasms/metabolism , Gallstones/epidemiology , Gallstones/metabolism , Humans , Immunohistochemistry , India/epidemiology , Male , Middle Aged , Real-Time Polymerase Chain Reaction , Telomere , Young Adult
9.
Infect Genet Evol ; 12(5): 1120-7, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22554651

ABSTRACT

The association of genetic variants of chemokines, CCL2 [MCP-1 (monocyte chemoattractant protein-1)], CCL5 [RANTES (regulated on activation, normal T-cell expressed and secreted)] and their receptors CCR2 and CCR5, respectively, earlier reported to be associated with susceptibility to pulmonary tuberculosis (PTB) in certain ethnic populations, were explored in Sahariya tribe, a primitive tribe of North Central India having a high prevalence of TB. We genotyped 215 cases and 215 controls of Sahariya tribe for polymorphisms in CCL2 (-2518A/G, -362G/C) by PCR-RFLP method and in CCR2 (V64I), CCL5 (-403G/A, -28C/G) and CCR5 (-59029G/A) by ARMS-PCR method. The frequencies of 'AA' genotype and 'A' allele of -403G/A were found significantly higher in cases than in controls (OR, 2.616 [95%CI, 1.302-5.320] and OR, 1.348 [95%CI, 0.980-1.853], respectively). Conversely, the frequencies of 'AA' genotype and 'A' allele of V64I were significantly (p=0.05 and 0.04, respectively) higher in controls than in cases. Also, the "AA" genotype of V64I was found to provide significant (p=0.05) protection against high bacillary load (3+). Likewise, the comparison of frequencies of different combinations of these polymorphisms further strengthens the association of -403G/A with susceptibility and V64I with resistance to TB in Sahariya tribe. However, no significant association of other polymorphisms with either resistance or susceptibility to TB was found. Thus, our findings support the association of -403G/A and V64I polymorphisms with genetic susceptibility and resistance to TB, respectively , alone or in combination with other polymorphisms in Sahariya tribe.


Subject(s)
Chemokine CCL2/genetics , Chemokine CCL5/genetics , Receptors, CCR2/genetics , Receptors, CCR5/genetics , Tuberculosis, Pulmonary/genetics , Adult , Chi-Square Distribution , Female , Genetic Predisposition to Disease , Haplotypes , Humans , India/epidemiology , Linkage Disequilibrium , Male , Odds Ratio , Polymorphism, Single Nucleotide , Tuberculosis, Pulmonary/epidemiology , White People/genetics
10.
Indian J Hum Genet ; 18(3): 299-304, 2012 Sep.
Article in English | MEDLINE | ID: mdl-23716937

ABSTRACT

BACKGROUND: Spinocerebeller ataxia type 1 (SCA1) is a specific type of ataxia among a group of inherited diseases of the central nervous system. In SCA1, genetic defects lead to impairment of specific nerve fibers carrying messages to and from the brain, resulting in the degeneration of the cerebellum, the coordination center of the brain. We investigated 24 members of an extended family in Gwalior city, India, some of which were earlier clinically diagnosed to be suffering from yet unconfirmed type of SCA neurodegenerative disorder. MATERIALS AND METHODS: All the family members from each age group were screened clinically and the characteristics of those resembling with ataxia were recorded for diagnosis by MRI. The confirmed patients of the family were genetically tested by PCR based molecular testing to identify the type of SCA (i.e., SCA 1, 2, 3, 4, 6 or 7). Family tree of the disease inheritance was constructed by pedigree based method. RESULT AND CONCLUSION: We found the clinical (symptoms and MRI) and genetic (Pedigree and PCR) results to be correlated. The PCR result revealed the disease to be of SCA 1 type being inherited in the family.

SELECTION OF CITATIONS
SEARCH DETAIL
...